| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology, Yamaguchi University School of Medicine, Japan.
1. Intravenous (I.V.) injection of human recombinant interleukin-1 alpha (IL-1 alpha) produced dose-dependent monophasic fevers in rats. Moreover, the I.V. injection of IL-1 alpha produced dose-dependent rises in the plasma concentrations of adrenocorticotrophic hormone (ACTH) 30 min after injections with dosages of 5 micrograms/kg and 15 micrograms/kg of IL-1 alpha. 2. The febrile responses induced by the I.V. injection of IL-1 alpha (15 micrograms/kg) were completely abolished, and conversely hypothermia occurred, when the animals were pre-treated with a cyclo-oxygenase inhibitor, indomethacin (INDO). Pre-treatment with INDO also inhibited the increase in the plasma concentrations of ACTH induced by I.V. injection of IL-1 alpha (15 micrograms/kg), indicating that enhancement of plasma concentrations of ACTH induced by I.V. injection of IL-1 alpha is processed through the action of prostaglandins. 3. Intrapreoptic injection of prostaglandin E2 produced a dose-dependent fever with a rapid onset at doses of 25 and 100 ng. Moreover, the intrapreoptic injection of prostaglandin E2 increased the plasma concentrations of ACTH in a dose-dependent manner 30 min after injections. 4. The intrapreoptic injection of IL-1 alpha (20 ng) caused slow monophasic fever. However, no significant elevation of plasma concentrations of ACTH was observed 30, 90 and 180 min after the intrapreoptic injection of IL-1 alpha, as compared with the ACTH levels at each time in the control group which received an intrapreoptic injection of saline. 5. These results suggest that intrapreoptic prostaglandin E plays an important role in the ACTH response by inducing the release of corticotrophin-releasing factor (CRF).
This article has been cited by other articles:
|
|
 |
|
  L. Engstrom, K. Rosen, A. Angel, A. Fyrberg, L. Mackerlova, J. P. Konsman, D. Engblom, and A. Blomqvist Systemic Immune Challenge Activates an Intrinsically Regulated Local Inflammatory Circuit in the Adrenal Gland Endocrinology, April 1, 2008; 149(4): 1436 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Matsuoka, T. Furuyashiki, H. Bito, F. Ushikubi, Y. Tanaka, T. Kobayashi, S. Muro, N. Satoh, T. Kayahara, M. Higashi, et al. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes PNAS, April 1, 2003; 100(7): 4132 - 4137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Schiltz and P. E. Sawchenko Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults J. Neurosci., July 1, 2002; 22(13): 5606 - 5618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Nardo, Y. Soong, D. Wu, I. R. Young, D. Walker, and H. H. Szeto Site and mechanism of action of dynorphin A-(1-13) and N-methyl-D-aspartate on ACTH release in fetal sheep Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1301 - E1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Shemi, A.N. Azab, and J. Kaplanski Time-dependent effect of LPS on PGE2 and TNF-{alpha} production by rat glial brain culture: influence of COX and cytokine inhibitors Innate Immunity, October 1, 2000; 6(5): 377 - 381. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid Receptors: Structures, Properties, and Functions Physiol Rev, October 1, 1999; 79(4): 1193 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ek, M. Kurosawa, T. Lundeberg, and A. Ericsson Activation of Vagal Afferents after Intravenous Injection of Interleukin-1beta : Role of Endogenous Prostaglandins J. Neurosci., November 15, 1998; 18(22): 9471 - 9479. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
